ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 732737 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 732737; 2) Community: the network communities that were significantly associated with the response to NSC 732737; 3) Molecule: the relationships between components within communities and NSC 732737; 4) MDR: the compounds that were significantly associated with the NSC 732737.

NSC Compound Enrichment Correlation
NSC 678914 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride 0.00433056621075589 0.28292336
NSC 698960 Null 0.00433056621075589 0.23777817
NSC 708062 Null 0.00433056621075589 0.39910004
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.00433056621075589 0.2722526
NSC 92504 Null 0.00433056621075589 0.30551769
NSC 120958 Kinetin ribonucleoside 0.00567322425730621 0.36827125
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.00567322425730621 0.47229215
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.00567322425730621 0.34813808
NSC 606497 Camptothecin Derivative 0.00567322425730621 0.17486408
NSC 652536 Null 0.00567322425730621 0.22669272
Total:101  Current:20    [First] [Prev] [Next] [Last]